Read about Recursive’s Flint AI coding model, its laptop-friendly design, coding benchmarks, open-source license, and Eureka ...

For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...

What happens when artificial intelligence systems start to think for themselves, make themselves more powerful and escape human control in their quest to achieve superintelligence? That prospect has ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Dario Amodei, CEO and co-founder of Anthropic ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...

Recursive self-improvement could, in theory, lead to superintelligent AI. That is the short answer. The harder answer is that today's systems only show bounded, supervised self-refinement, not a ...

Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...

【免费下载链接】freeCodeCamp freeCodeCamp.org's open-source codebase and curriculum. Learn math, programming, and computer science for free. 项目地址 ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated ...